Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes.

Chunhong Shi Ru Zhang Ran Bai Dan Liu Yongbo Wang Xueyang Zhang Hao Wang Jianling Du

Published in: Clinics (Sao Paulo, Brazil) (2019)

Sitagliptin added to combined metformin and insulin therapy showed greater efficacy and good safety regarding hypoglycemia in patients with newly diagnosed T2DM compared with voglibose.

Keyphrases

newly diagnosed
type diabetes
glycemic control
insulin resistance
weight loss
stem cells
adipose tissue
cell therapy
mesenchymal stem cells